How Listening Tech Disrupts Clinical Research to Create Patient-Centric Trials

About This Episode: 

Current efforts to source and disseminate patient insights in clinical trial planning are expensive and time-consuming. 

In this episode, Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD Research, discusses how patient voice listening technology is enhancing and disrupting clinical research by making it easier to collect and use patient responses. The result could be more patient-centric trials informed by the actual patient voice. 

Key Takeaways:

• How current listening technology can accurately capture and convey patient responses, emotion and perspective
• The difference from current methods of sourcing patient feedback
• Next steps in the journey of making trials more patient-centric

About the Speaker: 

Fabio Gratton, Co-Founder and CEO of inVibe, part of THREAD Research, is a digital health entrepreneur. For over two decades he has adapted his early experience as a Hollywood scriptwriter with innate acumen in science and data to redefine how healthcare companies tell patient stories through technology. Of his many Fortune 5000 ventures, inVibe has transformed market research by enabling
brands to supplement their efforts with flexible, scalable, and impactful voice-driven insights.

For more information about innovation in clinical research, click here. For more information about mobile technologies in clinical trials, click here.